Skip to main navigation Skip to search Skip to main content

Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis

  • S. C. Sasson
  • , J. J. Zaunders
  • , K. Nahar
  • , C. M. L. Munier
  • , B. P. Fairfax
  • , A. Olsson-Brown
  • , C. Jolly
  • , S. A. Read
  • , G. Ahlenstiel
  • , U. Palendira
  • , R. A. Scolyer
  • , M. S. Carlino
  • , M. J. Payne
  • , V. T. F. Cheung
  • , T. Gupta
  • , P. Klenerman
  • , G. V. Long
  • , O. Brain
  • , A. M. Menzies
  • , A. D. Kelleher

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)
4 Downloads (Pure)

Abstract

The aim of this study was to investigate the pathogenesis of combination ipilimumab and nivolumab-associated colitis (IN-COL) by measuring gut-derived and peripheral blood mononuclear cell (GMNC; PBMC) profiles. We studied GMNC and PBMC from patients with IN-COL, IN-treated with no adverse-events (IN-NAE), ulcerative colitis (UC) and healthy volunteers using flow cytometry. In the gastrointestinal-derived cells we found high levels of activated CD8+ T cells and mucosal-associated invariant T (MAIT) cells in IN-COL, changes that were not evident in IN-NAE or UC. UC, but not IN-C, was associated with a high proportion of regulatory T cells (Treg). We sought to determine if local tissue responses could be measured in peripheral blood. Peripherally, checkpoint inhibition instigated a rise in activated memory CD4+ and CD8+ T cells, regardless of colitis. Low circulating MAIT cells at baseline was associated with IN-COL patients compared with IN-NAE in one of two cohorts. UC, but not INCOL, was associated with high levels of circulating plasmablasts. In summary, the alterations in T cell subsets measured in IN-COL-affected tissue, characterized by high levels of activated CD8+ T cells and MAIT cells and a low proportion of Treg, reflected a pathology distinct from UC. These tissue changes differed from the periphery, where T cell activation was a widespread on-treatment effect, and circulating MAIT cell count was low but not reliably predictive of colitis.
Original languageEnglish
Pages (from-to)335-352
Number of pages18
JournalClinical and Experimental Immunology
Volume202
Issue number3
DOIs
Publication statusPublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020 The Authors. Clinical & Experimental Immunology published by John Wiley and Sons Ltd on behalf of British Society for Immunology

Open Access - Access Right Statement

© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Keywords

  • T cells
  • colitis

Fingerprint

Dive into the research topics of 'Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis'. Together they form a unique fingerprint.

Cite this